82 related articles for article (PubMed ID: 1768611)
1. Effects of simultaneous diabetes and hypertension in an insulin dependent diabetic model.
Mozaffari MS; Jirakulsomchok S; Wyss JM
Int J Exp Pathol; 1991 Dec; 72(6):655-64. PubMed ID: 1768611
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.
Wyss JM; Mozaffari MS; St John PL; Abrahamson DR
Int J Exp Pathol; 1993 Dec; 74(6):615-26. PubMed ID: 8292559
[TBL] [Abstract][Full Text] [Related]
4. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats.
Schenk J; Hebden RA; Dai S; McNeill JH
Pharmacology; 1994 Apr; 48(4):211-5. PubMed ID: 8177907
[TBL] [Abstract][Full Text] [Related]
5. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes mellitus.
Hebden RA; Todd ME; Tang C; Gowen B; McNeill JH
Am J Physiol; 1990 Apr; 258(4 Pt 2):R1042-50. PubMed ID: 2331024
[TBL] [Abstract][Full Text] [Related]
6. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
Dai S; McNeill JH
Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
Sevak AR; Goyal RK
Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
[TBL] [Abstract][Full Text] [Related]
8. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes.
Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847
[TBL] [Abstract][Full Text] [Related]
9. Role of fibrillin-1 in hypertensive and diabetic glomerular disease.
Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460
[TBL] [Abstract][Full Text] [Related]
10. [The effect of diabetes mellitus on the renal prostanoid system and on the arterial pressure level in spontaneously hypertensive rats].
Markov KhM; Kucherenko AG; Fatkhullin IA
Patol Fiziol Eksp Ter; 1990; (2):10-2. PubMed ID: 2381740
[TBL] [Abstract][Full Text] [Related]
11. Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.
Janssen U; Riley SG; Vassiliadou A; Floege J; Phillips AO
Kidney Int; 2003 Jun; 63(6):2162-70. PubMed ID: 12753303
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of rat model of type 2 diabetes complicated with hypertension].
Huang JX; Chen ZS; Zhang Y; Zhang K; Chen YY; Chen LM; Zhou WW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):329-333. PubMed ID: 29926638
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.
Goyal RK; Satia MC; Bangaru RA; Gandhi TP
J Cardiovasc Pharmacol; 1998 Aug; 32(2):317-22. PubMed ID: 9700996
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and progression of experimental nephritis. Interaction between immunological and haemodynamic factors.
Tikkanen I; Miettinen A; Törnroth T; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():45-50. PubMed ID: 3912983
[TBL] [Abstract][Full Text] [Related]
15. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride.
Tatsuta M; Iishi H; Baba M; Taniguchi H
Cancer Res; 1991 Jun; 51(11):2863-6. PubMed ID: 2032226
[TBL] [Abstract][Full Text] [Related]
16. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
17. Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats.
Dai S; Fraser H; McNeill JH
Can J Physiol Pharmacol; 1992 Nov; 70(11):1468-72. PubMed ID: 1296859
[TBL] [Abstract][Full Text] [Related]
18. Plasma atrial natriuretic peptide in DOCA-NaCl-treated rats.
Tikkanen T; Tikkanen I; Fyhrquist F
Acta Physiol Scand; 1987 Feb; 129(2):151-5. PubMed ID: 2953170
[TBL] [Abstract][Full Text] [Related]
19. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
O'Donaughy TL; Brooks VL
Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
[TBL] [Abstract][Full Text] [Related]
20. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
Silambarasan T; Raja B
Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
